Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

Siemens opens to new radiopharmacies in the USA to support PET-CT technology

Siemens Healthcare USA : 17 June, 2008  (Company News)
Siemens Healthcare has opened two new radiopharmacies in Las Vegas and Pittsburgh to help ensure that more healthcare facilities throughout the USA have access to the positron emission tomography-computed tomography (PET-CT) technology that helps clinicians diagnose and treat disease earlier and more effectively.
These two new facilities will produce imaging biomarkers that are a crucial component of PET-CT tests used to diagnose cancer and cardiac and neurological ailments.

PETNET Solutions, a fully owned subsidiary of Siemens Medical Solutions USA, operates the largest PET radiopharmacy network with 50 radiopharmacies and distribution centres in the USA, Korea and the United Kingdom that produce and distribute PET radiopharmaceuticals to hospitals, clinics, and research facilities for PET imaging. The new facilities produce and supply the required radiopharmaceuticals to area hospitals that have PET-CT, which will help ease the burden of healthcare providers to produce their own radiopharmaceuticals.

The expansion into Las Vegas and Pittsburgh bolsters Siemens' goal to provide PETNET services to all US hospitals and imaging centres.

'Molecular imaging is a formidable tool for practitioners to understand disease better, intervene sooner, apply more tailored treatment and, ultimately, improve patient care,' said Michael Reitermann, chief executive officer, Molecular Imaging, Siemens Medical Solutions USA. 'By expanding the PETNET network, Siemens is helping to improve access to PET technology, an increasingly essential component to oncological, cardiac and neurological treatments.'

The Las Vegas facility, which opened in April 2008, will manufacture fluorodeoxyglucose (FDG), the imaging Biomarker used to assist with diagnosis and staging of disease processes and to monitor cellular response to treatments, such as chemotherapy and radiotherapy. The new Pittsburgh facility uses a Siemens Eclipse HP Cyclotron to produce FDG.
Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com
Netgains Logo